Eli Lilly seals $1bn genetics deal
Jonathan Weiss / Shutterstock.com
The US Court of Appeals for the Federal Circuit last week affirmed two findings that Dr Reddy’s and Hospira had infringed Eli Lilly’s cancer drug Alimta (pemetrexed).
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Eli Lilly, Dr Reddy’s, Hospira, US Court of Appeals for the Federal Circuit, Alimta, cancer drug, generics